Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.

IF 3.1 4区 医学 Q2 PHARMACOLOGY & PHARMACY Cannabis and Cannabinoid Research Pub Date : 2024-08-01 Epub Date: 2023-04-25 DOI:10.1089/can.2022.0324
Daniel J Kruger, Joseph Gerlach, Jessica S Kruger, Majd A Mokbel, Daniel J Clauw, Kevin F Boehnke
{"title":"Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.","authors":"Daniel J Kruger, Joseph Gerlach, Jessica S Kruger, Majd A Mokbel, Daniel J Clauw, Kevin F Boehnke","doi":"10.1089/can.2022.0324","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Medical cannabis users tend not to trust or rely on health care providers regarding cannabis advice. Previous surveys of physicians have focused on favorability toward medical cannabis. The current study assesses how physicians interact with patients regarding cannabis in their day-to-day practice, and whether and how they address important topics such as use patterns and substituting cannabis for medications. We predicted that physicians would generally perceive cannabis dispensary staff and caretakers as not competent in addressing patient health needs and would not be likely to use their recommendations. <b>Methods:</b> Physicians in a university-affiliated health system completed an anonymous online survey. The survey assessed physicians' cannabis related education experiences, perceptions of their knowledge of and competence regarding medical cannabis, and the content of cannabis related discussions with patients. We also examined perceptions of the sources of influence on patients regarding cannabis and physicians' attitudes toward medical cannabis dispensary staff and medical cannabis caregivers (MCCs). <b>Results:</b> A few physicians (10%) had ever signed a medical cannabis authorization form for their patients, consistent with their perceptions of low knowledge and competence in this area. Discussions on cannabis primarily focus on risks (63%) rather than dosage (6%) and harm reduction (25%). Physicians see their influence on patients as weak compared with other information sources and have generally unfavorable attitudes toward medical cannabis dispensary staff and MCCs. <b>Conclusion:</b> Greater integration of medical cannabis knowledge is needed at all levels of medical and clinical education to address the potential harm to patients if they receive no guidance. Continued research is needed to provide a strong scientific basis for developing treatment guidelines and standardized medical education for medical cannabis use.</p>","PeriodicalId":9386,"journal":{"name":"Cannabis and Cannabinoid Research","volume":" ","pages":"e1048-e1055"},"PeriodicalIF":3.1000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11538087/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cannabis and Cannabinoid Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/can.2022.0324","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Medical cannabis users tend not to trust or rely on health care providers regarding cannabis advice. Previous surveys of physicians have focused on favorability toward medical cannabis. The current study assesses how physicians interact with patients regarding cannabis in their day-to-day practice, and whether and how they address important topics such as use patterns and substituting cannabis for medications. We predicted that physicians would generally perceive cannabis dispensary staff and caretakers as not competent in addressing patient health needs and would not be likely to use their recommendations. Methods: Physicians in a university-affiliated health system completed an anonymous online survey. The survey assessed physicians' cannabis related education experiences, perceptions of their knowledge of and competence regarding medical cannabis, and the content of cannabis related discussions with patients. We also examined perceptions of the sources of influence on patients regarding cannabis and physicians' attitudes toward medical cannabis dispensary staff and medical cannabis caregivers (MCCs). Results: A few physicians (10%) had ever signed a medical cannabis authorization form for their patients, consistent with their perceptions of low knowledge and competence in this area. Discussions on cannabis primarily focus on risks (63%) rather than dosage (6%) and harm reduction (25%). Physicians see their influence on patients as weak compared with other information sources and have generally unfavorable attitudes toward medical cannabis dispensary staff and MCCs. Conclusion: Greater integration of medical cannabis knowledge is needed at all levels of medical and clinical education to address the potential harm to patients if they receive no guidance. Continued research is needed to provide a strong scientific basis for developing treatment guidelines and standardized medical education for medical cannabis use.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医生对大麻和推荐使用医用大麻的态度和做法。
导言:医用大麻使用者在大麻建议方面往往不信任或依赖医疗服务提供者。以往对医生的调查主要集中在对医用大麻的好感度上。本研究评估了医生在日常工作中如何就大麻问题与患者互动,以及他们是否和如何处理使用模式和用大麻替代药物等重要话题。我们预测,医生会普遍认为大麻药房的工作人员和护理人员没有能力满足患者的健康需求,并且不太可能使用他们的建议。方法:一所大学附属医疗系统的医生完成了一项匿名在线调查。调查评估了医生的大麻相关教育经历、对其医用大麻知识和能力的看法以及与患者进行大麻相关讨论的内容。我们还调查了医生对影响患者使用大麻的来源的看法,以及医生对医用大麻药房工作人员和医用大麻护理人员 (MCC) 的态度。结果:只有少数医生(10%)曾为患者签署过医用大麻授权书,这与他们认为自己在这一领域的知识和能力不足相一致。关于大麻的讨论主要集中在风险(63%)上,而不是剂量(6%)和减少危害(25%)。与其他信息来源相比,医生认为他们对患者的影响力较弱,并且普遍对医用大麻药房工作人员和医管中心持不利态度。结论:需要在各级医学和临床教育中更多地融入医用大麻知识,以解决患者在没有指导的情况下可能受到的伤害。需要继续开展研究,为制定医用大麻使用的治疗指南和标准化医学教育提供坚实的科学依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cannabis and Cannabinoid Research
Cannabis and Cannabinoid Research PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
7.90%
发文量
164
期刊最新文献
Drug Interactions in People on Cannabidiol: Is There Cause for Concern? Federal Courts Will No Longer Need to Follow the DEA's Interpretation of Cannabis-Related Law. Minor Cannabinoid Profile of Unregulated Cannabidiol Products. Technology-Based Psychotherapeutic Interventions for Decreasing Cannabis Use in People with Psychosis: A Systematic Review Update. Biological Response after 14-Day Cannabidiol and Propylene Glycol Inhalation in Sprague-Dawley Rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1